ThomasDSchianoMD

Hepatology & Liver Transplantation, Nutrition

Professor of Medicine, Mount Sinai School of Medicine Medical Director, Liver Transplantation Medical Director, Intestinal Transplantation Director, Clinical Hepatology

Join to view full profile

Dr. Schiano is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Schiano's full profile

Already have an account?

Office
5 E 98th St
12th Fl
New York, NY 10029
Phone+1 212-241-0034

Fax+1 212-289-7738

Education & Training

Icahn School of Medicine at Mount SinaiFellowship, Transplant Hepatology, 1995 - 1996
Temple University HospitalFellowship, Gastroenterology, 1993 - 1995
Memorial Sloan Kettering Cancer CenterFellowship, Clinical Nutrition, 1992 - 1993
Maimonides Medical CenterChief Residency, Internal Medicine, 1991 - 1992
Maimonides Medical CenterResidency, Internal Medicine, 1988 - 1992
Universidad del NoresteClass of 1987

Certifications & Licensure

NY State Medical License 1989 - 2026
NJ State Medical License 2016 - 2025
IL State Medical License 1996 - 1999
PA State Medical License 1993 - 1996

Awards, Honors, & Recognition

New York Magazine: Top Doctors Castle Connolly, 2009-2014
America's Top Doctors Castle Connolly, 2009-2014
Top Doctors: New York Metro Area Castle Connolly, 2009-2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Fellow (FACP) American College of Physicians, 1999
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction Start of enrollment: 2003 Oct 01
Completed
Not Applicable
CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL") Start of enrollment: 2012 Oct 29
Completed
Phase 4
Study of Hepatitis C Virus (HCV) Entry Inhibitor in Liver Transplant Recipients With HCV Infection Start of enrollment: 2012 Mar 01
Terminated
Phase 1
Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients Start of enrollment: 2012 Aug 01
Completed
Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients. Start of enrollment: 2013 Jun 01
Completed
Phase 3
Assessment of Intrahepatic Hepatitis C Virus (HCV) RNA Levels at the Time of Liver Transplantation Start of enrollment: 2013 Jun 01
Unknown status
CM-101 in PSC Patients -The SPRING Study Start of enrollment: 2020 Oct 01
Active, not recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

Abstracts/Posters

Utility of Thrombophilia Testing in Portal Vein Thrombosis in a Large Single Institutional Cohort
Thomas Schiano, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
The Use of Direct Oral Anticoagulants in Non-Cirrhotic Portal Vein Thrombosis
Thomas Schiano, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

Alcohol-Related Health Issues on the Rise in Young AdultsJanuary 16th, 2023
‘Every Day, I’m Grateful’; Young Woman Donates Liver to Twin SisterDecember 24th, 2021
Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein ThrombosisNovember 5th, 2020
Join now to see all